You can buy or sell EUCR and other stocks, options, and ETFs commission-free!
Eucrates Biomedical Acquisition Corp. operates as a blank Check company focusing on acquiring, engaging in a share exchange, share reconstruction and amalgamations. The company was founded by Stelios Papadopoulos, Parag Saxena, Evangelos Vergetis and Daphne Karydas on August 21, 2020 and is headquartered in New York, NY. The listed name for EUCR is Eucrates Biomedical Acquisition Corp. Ordinary Shares.
New York, New York
52 Week High
52 Week Low